Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 1238

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 1238
---

  
    Assets 

    Marketable Securities: 

    United States Treasury Bonds 
    $—  
    $—  
    $—  
    $— 
  
    Total Assets 
    $—  
    $—  
    $—  
    $— 
  
    Liabilities 

    Derivative Liability - Warrants 
    $—  
    $—  
    $25,281  
    $25,281 
  
    Derivative Liability - Accelerated feature 
     —  
     —  
     —  
     — 
  
    Convertible Note 
    $—  
    $—  
    $684,205  
    $684,205 
  
    Total Liabilities 
    $—  
    $—  
    $709,486  
    $709,486 

    December 31, 2023 
    Level 1  
    Level 2  
    Level 3  
    Carrying Value 
  
    Assets 

    Marketable Securities: 

    United States Treasury Bonds 
    $2,887,215  
    $—  
    $—  
    $2,887,215 
  
    Total Assets 
    $2,887,215  
    $—  
    $—  
    $2,887,215 
  
    Liabilities 

    Derivative Liability - Warrants 
    $—  
    $—  
    $410,660  
    $410,660 
  
    Derivative Liability - Accelerated feature 
     —  
     —  
     3,852  
     3,852 
  
    Derivative Liability 
     —  
     —  
     3,852  
     3,852 

    Total Liabilities 
    $—  
    $—  
    $414,512  
    $414,512 

See
Note 5 and Note 7 for additional disclosures related to the fair value of the Company’s convertible notes and derivative liabilities,
respectively.

Leases

The
Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use asset (“ROU”),
operating lease liability - current, and operating lease liability - noncurrent on the consolidated balance sheets.

ROU
assets represent the Company’s